Can a smartphone app help young adults tame type 2 diabetes?
NCT ID NCT07325838
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a 12-week digital program led by a nurse to help young adults (ages 18-45) with type 2 diabetes better manage their condition. Participants use a web or mobile app for education, goal-setting, and direct messaging with a nurse. The goal is to see if this approach improves blood sugar control, self-care habits, and reduces diabetes-related distress compared to standard care plus digital brochures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Digital nurse-led self-management education and support program
What this could lead to
If successful, this could provide an effective, scalable way to help young adults with type 2 diabetes better manage their condition and reduce diabetes-related distress.
What could go wrong
This is a small, early-stage trial with 72 participants, so results may not apply broadly. The digital program may not be more effective than standard education, and adherence could be low.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Van Regional Training and Research Hospital, Endocrinology and Metabolism Clinic
Van, 65150, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••